Medical cannabis became available through individual special permits, with one permit recorded in 2006 and one in 2007. This was a narrow route for named patients, not general marketing authorisation: a 2011 report described annual permits and specialist assessment after other treatments proved unsuitable or ineffective. Sativex's separate marketing authorisation followed in 2012.[1]
Score by segment 0 to 10
- Possession · 25%1 → 1
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%3 → 3
- Sharing & gifting · 10%1 → 1
- Consumption · 10%1 → 1
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. The scores after the change are Finland's current scores.
References
- Yle — Lääkekannabiksen käyttö on moninkertaistunut (28 October 2011, updated 7 June 2012)Permit counts for 2006–2011 and interviews with Fimea officials; patient-specific permit conditionsarchived
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.